News und Analysen

Union Pacific Corporation (NYSE: UNP) will release fourth quarter 2024 financial and operating results on Thursday, Jan. 23, 2025, at 7:45 a.m. ET. The company’s management team will host a

Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that it has reached mutually beneficial agreements with Brookdale Senior Living (“Brookdale”) regarding all assets under the

CarMax, Inc. (NYSE:KMX) today reported results for the third quarter ended November 30, 2024.

Third Quarter Highlights:⁽¹⁾

• 
  Retail used unit sales increased 5.4% and comparable store used

Trane Technologies (NYSE: TT), a global climate innovator, announced that it has signed a definitive agreement to acquire BrainBox AI, a pioneer in autonomous HVAC controls and generative

The Board of Directors of Xcel Energy Inc. (NASDAQ: XEL) today declared a quarterly dividend on its common stock of 54.75 cents per share. The dividends are payable January 20, 2025, to

The Board of Directors of Xcel Energy Inc. (NASDAQ: XEL) today declared a quarterly dividend on its common stock of 54.75 cents per share. The dividends are payable January 20, 2025, to

The Board of Directors of Xcel Energy Inc. (NASDAQ: XEL) today declared a quarterly dividend on its common stock of 54.75 cents per share. The dividends are payable January 20, 2025, to

Fifth Third Bank, National Association, today announced it will decrease its prime lending rate to 7.50%, effective immediately.

The rate was last changed on November 7, 2024, when Fifth Third

Fifth Third Bank, National Association, today announced it will decrease its prime lending rate to 7.50%, effective immediately.

The rate was last changed on November 7, 2024, when Fifth Third

Freeport (NYSE: FCX) announced today that its Board of Directors declared cash dividends of $0.15 per share on FCX’s common stock payable on February 3, 2025, to shareholders of record as of

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has renewed its long-standing enterprise partnership with ClinChoice, a global

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has renewed its long-standing enterprise partnership with ClinChoice, a global

TechnipFMC (NYSE: FTI) has been awarded a substantial⁽¹⁾ contract by Shell Nigeria Exploration and Production Company Limited to supply Subsea 2.0^® production systems for the Bonga North

TechnipFMC (NYSE: FTI) has been awarded a substantial⁽¹⁾ contract by Shell Nigeria Exploration and Production Company Limited to supply Subsea 2.0^® production systems for the Bonga North

TechnipFMC (NYSE: FTI) has been awarded a substantial⁽¹⁾ contract by Shell Nigeria Exploration and Production Company Limited to supply Subsea 2.0^® production systems for the Bonga North

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today it has launched a proprietary Generative AI (GenAI) platform, making Dexcom the first CGM manufacturer to

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today it has launched a proprietary Generative AI (GenAI) platform, making Dexcom the first CGM manufacturer to

Intuit Inc. (Nasdaq: INTU), the global financial technology platform that makes Intuit TurboTax, Credit Karma, QuickBooks, and Mailchimp, and ICIC, the foremost authority on accelerating small

Intuit Inc. (Nasdaq: INTU), the global financial technology platform that makes Intuit TurboTax, Credit Karma, QuickBooks, and Mailchimp, and ICIC, the foremost authority on accelerating small

Intuit Inc. (Nasdaq: INTU), the global financial technology platform that makes Intuit TurboTax, Credit Karma, QuickBooks, and Mailchimp, and ICIC, the foremost authority on accelerating small

Salesforce (NYSE: CRM), the #1 AI CRM, today announced an expanded collaboration with the Adecco Group (SIX: ADEN), the world’s leading talent company, to reimagine recruiting and support for job

Pfizer Inc. (NYSE:PFE) today provided its full-year 2025 guidance⁽¹⁾ and reaffirmed its October 29, 2024 full-year 2024 guidance⁽¹⁾. The accompanying presentation can be found at www.pfizer.com/inv

Pfizer Inc. (NYSE:PFE) today provided its full-year 2025 guidance⁽¹⁾ and reaffirmed its October 29, 2024 full-year 2024 guidance⁽¹⁾. The accompanying presentation can be found at www.pfizer.com/inv

SLB (NYSE: SLB) wird zur Besprechung der Ergebnisse des vierten Quartals und des Geschäftsjahres zum 31. Dezember 2024 am 17. Januar 2025 eine Telefonkonferenz abhalten.

Der Beginn der Konferenz